Moderna Covid-19 vaccine stability could give it edge over Pfizer's version


Moderna Inc’s experimental COVID-19 vaccine is more stable than expected at temperatures that ordinary refrigerators can provide and can be distributed using existing cold-chain shipping and storage infrastructure. That opens the door for its early use in hard to reach places that might not be appropriate for Pfizer Inc’s vaccine which needs ultra-cold storage.

Here are details of how it could be distributed. HOW COLD IS COLD STORAGE?   Moderna’s vaccine is stable for up to six months at a temperature.

This article is no longer available in our repository.

There could be multiple reasons for this.